Xstrata Nickel Invest $95m in West Tanzanian Nickel Project

Xstrata Nickel announces further investment of US$95 million and the commencement of a pre-feasibility study to advance the Kabanga nickel project located in western Tanzania.

An update to the preliminary resource estimate has also been announced for the project, a 50/50 owned joint venture of Barrick Gold Corporation and Xstrata Nickel, operated by Xstrata through a subsidiary. This confirms the Kabanga nickel project as among the world’s most attractive undeveloped nickel sulphide deposits, with a total estimated indicated resource of 9.7 million tonnes grading 2.37% nickel and a total estimated inferred resource of 36.3 million tonnes grading 2.8% nickel. The revised estimate represents a notable increase from the project’s previous estimate (inferred) of 26.4 million tonnes at 2.6% nickel.

Xstrata Nickel has completed over US$50 million in expenditures to update the resource model for the Kabanga project and preparation of an extensive scoping study.
“We are very pleased with the progress occurring at Kabanga, which is among the world’s most attractive nickel projects,” said Ian Pearce, Chief Executive Officer of Xstrata Nickel. “We anticipated good results from our resource estimate update and we received them. We have taken the logical next step of moving this project to the pre-feasibility stage and we look forward to the continued development of Kabanga.”

“Kabanga has the potential to become a world class nickel sulphide deposit. The most recent resource has a compelling combination of size with high grades," said Greg Wilkins, Barrick President and Chief Executive Officer.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.